poisar

Stocks · News reference

Beyond COVID: Moderna Wins FDA Approval for Its Seasonal Flu Vaccine

BenzingaAug 6, 2026, 3:06 PMVandana Singh

Moderna receives FDA approval for mFLUSIVA, a new seasonal flu vaccine for adults 50 and older, launching for the 2026-2027 virus season.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 6, 2026, 3:06 PM
Checked
Aug 6, 2026, 3:06 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading